Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.355 USD | -4.58% | +6.35% | +137.17% |
May. 09 | Earnings Flash (NKTR) NEKTAR THERAPEUTICS Reports Q1 Revenue $21.6M, vs. Street Est of $15.3M | MT |
May. 09 | Nektar Therapeutics Reiterates Earnings Guidance for the Year 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+137.17% | 261M | |
+43.42% | 749B | |
+39.42% | 605B | |
-6.36% | 351B | |
+19.64% | 328B | |
+8.73% | 292B | |
+11.92% | 216B | |
-2.62% | 214B | |
+0.47% | 167B | |
+6.47% | 165B |
- Stock Market
- Equities
- NKTR Stock
- News Nektar Therapeutics
- Nektar Therapeutics Begins Phase 2b Trial for Rezpegaldesleukin in Patients With Severe Alopecia Areata